Astellas Pharma Inc. (TYO:4503)

Astellas Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 19, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,993,398	2,589,390	2,946,773	3,381,409	3,519,738	3,161,421
Market Cap Growth	-11.05%	-12.13%	-12.85%	-3.93%	11.33%	1.80%
Enterprise Value	3,667,489	3,324,889	3,565,926	3,003,971	3,170,189	2,856,153
Last Close Price	1672.00	1446.50	1568.52	1731.50	1701.96	1476.62
PE Ratio	36.84	51.03	172.88	34.26	28.37	26.22
Forward PE	17.10	18.73	21.06	15.87	16.50	15.21
PS Ratio	1.54	1.35	1.84	2.23	2.72	2.53
PB Ratio	2.02	1.71	1.85	2.24	2.41	2.28
P/TBV Ratio	70.26	-	-	5.48	6.59	7.02
P/FCF Ratio	14.90	16.44	21.92	11.61	15.53	11.48
P/OCF Ratio	12.64	13.31	17.09	10.32	13.67	10.30
PEG Ratio	0.31	0.17	1.48	0.68	0.70	2.26
EV/Sales Ratio	1.89	1.74	2.22	1.98	2.45	2.29
EV/EBITDA Ratio	7.61	7.19	12.63	8.90	10.64	8.83
EV/EBIT Ratio	12.87	12.62	28.62	12.97	14.53	11.38
EV/FCF Ratio	18.25	21.11	26.53	10.31	13.98	10.37
Debt / Equity Ratio	0.60	0.62	0.63	0.14	0.15	0.20
Debt / EBITDA Ratio	1.83	2.03	3.57	0.61	0.72	0.86
Debt / FCF Ratio	4.43	5.95	7.50	0.70	0.94	1.01
Asset Turnover	0.55	0.55	0.53	0.63	0.56	0.54
Inventory Turnover	1.26	1.28	1.38	1.76	1.60	1.56
Quick Ratio	0.81	0.79	0.69	1.13	1.05	1.15
Current Ratio	1.17	1.13	0.93	1.45	1.34	1.47
Return on Equity (ROE)	5.17%	3.26%	1.10%	6.65%	8.72%	9.01%
Return on Assets (ROA)	5.10%	4.77%	2.58%	6.05%	5.92%	6.83%
Return on Capital (ROIC)	7.16%	6.52%	3.61%	8.55%	8.17%	9.31%
Return on Capital Employed (ROCE)	13.00%	11.60%	5.50%	13.40%	13.30%	14.90%
Earnings Yield	2.72%	1.96%	0.58%	2.92%	3.52%	3.81%
FCF Yield	6.71%	6.08%	4.56%	8.62%	6.44%	8.71%
Dividend Yield	4.67%	5.12%	4.46%	3.46%	2.94%	2.84%
Payout Ratio	162.41%	254.19%	684.38%	101.66%	68.69%	63.15%
Buyback Yield / Dilution	0.10%	0.14%	1.39%	1.38%	0.41%	1.03%
Total Shareholder Return	4.81%	5.25%	5.85%	4.84%	3.35%	3.88%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.